Inventor · disambiguated record
Katherine Taylor
Also filed as: TAYLOR KATHERINE · TAYLOR KATHERINE D
4 granted patents·10 pending applications·15 citations·filing 2008–2024
72Inventor score
Files withSHIRE HUMAN GENETIC THERAPIES7OAK HILL BIO LTD2SALAMAT-MILLER NAZILA2TAKEDA PHARMACEUTICALS CO2STURK LISA MARIE1
Top patents by PatentIndex Score
14 records- 0193US2025161417A1Methods and compositions for cns delivery of arylsulfatase aTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0290US10660944B2Stable formulations for CNS delivery of arylsulfatase ASHIRE HUMAN GENETIC THERAPIES·Filed 2018·Granted May 26, 2020·5 cites·23 claims
- 0380US9770410B2Methods and compositions for CNS delivery of arylsulfatase ASALAMAT-MILLER NAZILA·Filed 2011·Granted Sep 26, 2017·10 cites·32 claims
- 0475US12168041B2Methods and compositions for CNS delivery of arylsulfatase ATAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Dec 17, 2024·0 cites·6 claims
- 0573US10646554B2Methods and compositions for CNS delivery of arylsulfatase ASHIRE HUMAN GENETIC THERAPIES·Filed 2017·Granted May 12, 2020·0 cites·19 claims
- 0661US2020237883A1Stable formulations for cns delivery of arylsulfatase aSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
- 0760US2010291060A1Subcutaneous administration of alpha-galactosidase aSHIRE HUMAN GENETIC THERAPIES·Filed 2008·Application pending·0 cites
- 0859US2025099541A1Compositions and methods for reducing oxidation of igf-1/igfbpOAK HILL BIO LTD·Filed 2023·Application pending·0 cites
- 0959US2014377244A1Stable formulations for cns delivery of arylsulfatase aSHIRE HUMAN GENETIC THERAPIES·Filed 2012·Application pending·0 cites
- 1052US2014037612A1Subcutaneous administration of alpha-galactosidase aSTURK LISA MARIE·Filed 2013·Application pending·0 cites
- 1150US2023381285A1Compositions suitable for use in neonatesOAK HILL BIO LTD·Filed 2021·Application pending·0 cites
- 1248US2013295071A1Methods and compositions for cns delivery of b-galactocerebrosidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Application pending·0 cites
- 1345US2015306187A1Subcutaneous administration of alpha-galactosidase aSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Application pending·0 cites
- 1440US2011318324A1Methods and compositions for cns delivery of b-galactocerebrosidaseSALAMAT-MILLER NAZILA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katherine Taylor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →